Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,20466,825,1.00 [0.82-1.22],0.9925083556873056
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19820,240,1.30 [0.91-1.86],0.1506111910170437
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22694,142,1.18 [0.74-1.87],0.4831505829491155
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15296,822,1.29 [1.05-1.58],0.013706052716374
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22654,102,0.99 [0.58-1.70],0.9733079906015694
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20547,93,2.53 [1.44-4.46],0.0013229802611144
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23714,101,0.99 [0.58-1.70],0.9700195239261824
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23725,69,0.94 [0.49-1.82],0.8633420324410257
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20117,53,2.46 [1.16-5.22],0.0191138670481755
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22705,121,1.54 [0.94-2.53],0.0861959409825011
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22670,86,2.61 [1.47-4.66],0.0011360820006735
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23801,57,1.42 [0.69-2.93],0.3443184881135256
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23827,66,1.41 [0.72-2.76],0.3216622664329585
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23819,58,1.64 [0.80-3.36],0.1755565030756007
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Mycoses,23475,42,0.92 [0.39-2.13],0.8401822376968855
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22533,392,0.94 [0.71-1.25],0.6821040941320666
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22294,153,0.85 [0.55-1.33],0.4891038152864324
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22408,267,1.02 [0.73-1.43],0.8939157442733366
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",18606,80,0.47 [0.26-0.88],0.0171110955638727
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18575,49,1.12 [0.51-2.46],0.7830339432559473
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18798,272,0.97 [0.70-1.37],0.8815586387106573
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18807,281,0.93 [0.67-1.30],0.6787002437819618
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18763,237,1.43 [1.00-2.04],0.048749793827108
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18581,55,2.39 [1.16-4.92],0.0177258652806548
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21151,565,1.98 [1.57-2.50],8.708246603746569e-09
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22300,379,0.82 [0.62-1.09],0.1698960165622572
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23216,127,0.77 [0.48-1.26],0.3028434825212424
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23866,135,0.86 [0.54-1.38],0.5364528152283977
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Rectum,23526,77,0.65 [0.35-1.21],0.1777617907752513
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23884,67,1.16 [0.60-2.25],0.6566633900510122
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Stomach,23931,49,1.40 [0.64-3.02],0.3971661808058221
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm,23604,321,0.71 [0.53-0.97],0.0319400034220284
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23892,110,0.99 [0.59-1.66],0.961390938229724
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23903,75,0.70 [0.37-1.32],0.2736191473777168
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23847,35,1.09 [0.43-2.74],0.8557941979812573
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma, any site",23850,35,1.09 [0.43-2.74],0.8560315987684527
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi,23778,130,0.77 [0.47-1.25],0.2838161907909882
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23909,55,0.65 [0.31-1.36],0.2486884080552747
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Other benign neoplasms of skin,23809,137,1.32 [0.82-2.10],0.2506136564882607
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22726,124,1.80 [1.11-2.91],0.0179143733673221
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22338,258,2.53 [1.81-3.55],6.968847523776212e-08
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22338,258,2.53 [1.81-3.55],6.968847523776212e-08
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),20090,519,1.13 [0.88-1.44],0.3490761419565105
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23400,42,2.16 [0.94-4.96],0.0690584601222061
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23669,62,3.16 [1.61-6.21],0.000830941226914
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18722,1450,1.07 [0.92-1.26],0.3724006248152492
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23206,182,1.02 [0.68-1.53],0.9138550056723412
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,21130,151,,
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22554,165,1.42 [0.93-2.17],0.1059853647513246
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21115,136,,
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21678,699,1.69 [1.36-2.10],2.1866417163841346e-06
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21651,672,1.63 [1.30-2.03],1.6058620183707074e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22166,172,0.86 [0.54-1.37],0.5170084521357059
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22166,171,0.84 [0.53-1.35],0.480746833557272
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,18568,1296,1.00 [0.84-1.17],0.955183085123501
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17457,185,0.87 [0.57-1.31],0.5019406444458498
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,18465,1193,1.00 [0.84-1.19],0.9882014637777924
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17323,51,2.97 [1.38-6.41],0.0055870396641743
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17372,100,1.60 [0.92-2.78],0.0948984318165264
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Any mental disorder,20299,691,0.92 [0.74-1.15],0.464597048978983
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19950,342,0.66 [0.49-0.91],0.010274591281854
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23357,264,0.70 [0.49-0.99],0.0437173521764885
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23447,201,0.66 [0.45-0.99],0.0432937507397871
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21809,80,0.62 [0.33-1.15],0.1275578028265308
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23782,80,0.65 [0.35-1.20],0.1643912555971411
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19688,80,0.61 [0.33-1.15],0.1275948025842161
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Alcohol dependence,21846,117,0.64 [0.38-1.08],0.0956366406651407
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Smoking dependency,21841,83,0.62 [0.33-1.13],0.119832614455261
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19674,66,1.20 [0.61-2.37],0.5998104015154955
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19876,268,0.98 [0.70-1.37],0.9078156647741932
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Depression,22728,230,0.86 [0.60-1.24],0.4151583164812933
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Depression or dysthymia,19581,196,0.80 [0.54-1.18],0.2624133062789895
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19715,107,0.95 [0.56-1.62],0.8568295960936346
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Other anxiety disorders,22927,58,1.06 [0.52-2.16],0.8779239484699362
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Neurological diseases,20255,1323,0.84 [0.71-0.98],0.0253053644931797
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18237,85,0.64 [0.34-1.17],0.1469619794069115
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23827,60,0.31 [0.15-0.63],0.0011340438286306
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22576,541,0.95 [0.75-1.21],0.6802213107272927
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Epilepsy,22202,167,0.80 [0.52-1.22],0.2925715733659024
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Migraine,22068,33,0.60 [0.23-1.56],0.2949954073302376
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23770,27,0.73 [0.25-2.08],0.5542256572338322
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22951,100,1.23 [0.71-2.13],0.4540130334952175
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other sleep disorders,22269,234,0.97 [0.68-1.40],0.8848576559857702
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Sleep apnoea,23192,184,0.97 [0.65-1.45],0.8783127796383698
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22963,473,1.10 [0.86-1.42],0.4449691897716004
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22614,124,0.87 [0.53-1.43],0.5899114775648224
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22710,220,1.12 [0.78-1.62],0.5424064877125763
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23579,89,0.31 [0.17-0.55],6.468295634572619e-05
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hemiplegia,23548,58,0.37 [0.18-0.76],0.006557101562223
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other neurological diseases,23419,122,0.74 [0.45-1.22],0.236514812124572
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23330,309,0.79 [0.58-1.08],0.1447263389130807
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23196,175,0.74 [0.49-1.12],0.1597097538081182
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23101,80,0.68 [0.37-1.26],0.2195713907993202
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23127,106,0.63 [0.37-1.07],0.089618942521071
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23071,50,1.59 [0.75-3.39],0.2270228017174188
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20906,144,1.10 [0.69-1.73],0.6947424206727303
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21148,386,1.29 [0.97-1.71],0.0760351041320829
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22951,253,1.89 [1.35-2.66],0.0002186303032612
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23523,71,4.66 [2.53-8.59],8.024336326436975e-07
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2614,71,3.57 [1.98-6.45],2.332089495045481e-05
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20980,71,5.59 [2.98-10.47],8.001711331367003e-08
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23264,97,1.16 [0.67-2.01],0.5883261461869427
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23219,52,1.92 [0.92-4.02],0.082805653512524
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23370,78,1.22 [0.66-2.26],0.5357816688381778
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23398,94,1.45 [0.83-2.53],0.1973518061115114
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23833,138,0.74 [0.47-1.18],0.2116206286429813
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22972,97,0.86 [0.49-1.50],0.5878672907941043
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16148,3779,1.08 [0.97-1.21],0.1698859032193505
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23226,62,1.04 [0.52-2.09],0.9050205407197592
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17048,2471,1.19 [1.05-1.36],0.0078988718555987
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertension,17093,2516,1.28 [1.13-1.46],0.0001568433554063
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14686,109,,
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21192,1686,1.05 [0.91-1.21],0.5315212458350667
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Angina pectoris,20448,942,1.03 [0.86-1.24],0.7520041532616772
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22477,340,1.40 [1.04-1.88],0.0258775715057397
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22879,742,1.29 [1.05-1.58],0.0135479580606747
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23724,164,1.62 [1.06-2.46],0.0249371809270626
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20013,507,1.18 [0.92-1.51],0.1882829399385215
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20923,1440,1.01 [0.86-1.17],0.9381866459166358
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23050,120,0.80 [0.48-1.31],0.3738758290581387
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23159,242,0.97 [0.69-1.38],0.8734483488357317
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23014,84,1.09 [0.60-1.98],0.7664254896023477
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23016,86,1.14 [0.63-2.05],0.6655709757635438
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14657,80,1.15 [0.61-2.16],0.6657993590426157
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18711,78,1.07 [0.57-2.01],0.8314784897817538
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Conduction disorders,18801,168,1.27 [0.82-1.94],0.2812544137860177
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11833,136,1.08 [0.65-1.78],0.7713320674379871
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,12303,606,0.80 [0.62-1.02],0.0706938696574873
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arrhythmias,18717,84,0.90 [0.49-1.65],0.7298787882367122
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18762,129,0.79 [0.48-1.29],0.3431441183434457
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22614,316,0.99 [0.73-1.35],0.9719939485059343
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22885,185,1.20 [0.81-1.80],0.3623070688186623
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22913,167,1.07 [0.70-1.63],0.749729964933531
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22999,148,1.13 [0.72-1.76],0.6010396169688281
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22526,88,1.07 [0.60-1.92],0.8105051822707305
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22585,147,1.17 [0.74-1.83],0.5025101455468801
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22576,152,0.92 [0.59-1.42],0.6990812166300691
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22560,136,0.92 [0.58-1.47],0.7418043563684013
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23694,129,0.88 [0.55-1.42],0.6073254025655024
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Varicose veins,22766,342,0.87 [0.64-1.17],0.3551562395413458
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypotension,22632,81,0.84 [0.45-1.54],0.5636787606604421
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18642,2020,0.92 [0.81-1.05],0.2422248322899399
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23756,87,0.65 [0.36-1.16],0.1432281298585771
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Influenza and pneumonia,21787,253,0.94 [0.67-1.33],0.7362688023784776
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",21750,216,1.11 [0.76-1.62],0.587846054829557
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22939,274,1.13 [0.81-1.57],0.4678789661648389
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22936,271,1.14 [0.82-1.59],0.4437599545192832
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23073,659,1.12 [0.90-1.39],0.2983940361488492
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic sinusitis,22489,75,0.93 [0.49-1.75],0.81827855391918
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Nasal polyp,22583,169,1.01 [0.66-1.54],0.9609759628628192
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22843,429,1.12 [0.86-1.46],0.4099195187659227
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Deviated nasal septum,22644,230,1.26 [0.87-1.81],0.2154083669325275
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10376,62,0.84 [0.41-1.74],0.6464504862108298
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21375,853,0.72 [0.60-0.88],0.0009845086808895
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Early onset COPD,22605,196,0.58 [0.39-0.87],0.0080819570558174
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22637,228,0.60 [0.42-0.87],0.0075019106558612
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22637,228,0.60 [0.42-0.87],0.0075019106558612
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22499,661,0.75 [0.60-0.92],0.0073703848317728
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Asthma,16254,661,0.70 [0.56-0.87],0.0014899153755723
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15906,661,0.70 [0.56-0.87],0.0015325751328006
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16244,651,0.69 [0.55-0.87],0.0013565169312707
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23498,100,0.80 [0.47-1.38],0.4297040967935991
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Interstitial lung disease,22748,79,0.74 [0.40-1.37],0.3318444138275324
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23581,79,0.74 [0.40-1.36],0.3301717529502528
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22741,72,0.58 [0.30-1.10],0.0973519479691419
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural effusion,21584,134,1.00 [0.62-1.61],0.9911431911377252
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of pleura,21736,286,0.92 [0.66-1.27],0.6022716642698758
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22548,128,0.67 [0.41-1.08],0.0991933791482802
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15921,5636,1.08 [0.98-1.19],0.1111859237823659
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23435,369,1.25 [0.94-1.67],0.1265367244776226
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23900,79,1.44 [0.77-2.69],0.2524730954192415
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impacted teeth,23903,76,1.50 [0.79-2.83],0.2108976581903526
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Dental caries,23177,111,1.57 [0.94-2.62],0.0875094702416174
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23147,81,1.30 [0.71-2.40],0.3903001085240853
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23890,88,1.33 [0.73-2.40],0.349046146079606
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23146,80,1.12 [0.61-2.06],0.7164149653474192
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22915,78,1.13 [0.61-2.10],0.7047710638942082
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23834,56,1.50 [0.73-3.10],0.2714810698330414
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18306,326,1.19 [0.87-1.62],0.2692955509067691
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19985,2005,1.04 [0.91-1.18],0.564266355398982
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophagitis,18369,389,1.02 [0.77-1.35],0.913075931229293
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18631,651,0.86 [0.69-1.07],0.1671187602217483
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18054,74,1.55 [0.82-2.93],0.1767729231142086
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18261,281,0.88 [0.63-1.23],0.459845086685994
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18054,74,0.67 [0.35-1.28],0.2237485638128151
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastric ulcer,18140,160,1.33 [0.87-2.05],0.1894176814019155
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Duodenal ulcer,18153,173,1.07 [0.70-1.63],0.74449448369335
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23736,118,1.04 [0.63-1.72],0.8664192851358742
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic gastritis,18093,113,0.86 [0.51-1.44],0.5604205854652107
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18761,781,1.02 [0.83-1.25],0.8433342089226394
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of appendix,23770,105,0.80 [0.47-1.38],0.4254934055264936
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Functional dyspepsia,18270,290,1.15 [0.83-1.59],0.400164332889605
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18141,161,0.97 [0.63-1.50],0.8848133850767015
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23724,168,1.43 [0.94-2.17],0.092069680618293
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute appendicitis,23750,85,0.79 [0.43-1.44],0.4374632163549312
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Hernia,20383,2068,0.90 [0.79-1.02],0.1018888115534258
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Inguinal hernia,19454,1139,0.89 [0.75-1.06],0.1884001450572281
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Umbilical hernia,18503,188,1.15 [0.78-1.72],0.4764294388090314
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ventral hernia,18411,96,0.67 [0.38-1.18],0.1647375349277927
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19084,769,0.91 [0.74-1.11],0.3480209138243507
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23056,606,1.75 [1.40-2.19],9.50328102043812e-07
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestines,18461,1815,1.03 [0.90-1.18],0.6732588364977274
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23593,55,2.65 [1.28-5.50],0.0087515728415003
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23856,71,2.92 [1.55-5.51],0.0009636657205852
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn disease,22521,71,3.01 [1.58-5.73],0.000777822259741
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22506,56,3.92 [1.92-8.03],0.0001839065106371
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23800,142,2.99 [1.91-4.67],1.5917752668586864e-06
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcerative colitis,22592,142,3.08 [1.96-4.83],1.0536099229289035e-06
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22578,128,3.43 [2.14-5.50],3.272876135377278e-07
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22909,459,1.41 [1.09-1.82],0.0091452250505158
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22906,456,1.42 [1.10-1.84],0.0074083860471088
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16739,93,0.91 [0.51-1.62],0.7430929572851279
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal stricture,23468,93,0.90 [0.51-1.58],0.7055887252357325
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16711,65,0.73 [0.37-1.46],0.3728447109059477
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17183,537,0.99 [0.78-1.27],0.9554851495566854
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16732,86,1.09 [0.60-1.99],0.7772865244807193
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16830,184,1.13 [0.75-1.70],0.5672456349120805
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Constipation,22343,168,1.15 [0.75-1.75],0.5292546283660033
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23534,53,0.73 [0.34-1.54],0.4059520565746872
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16805,159,1.49 [0.96-2.31],0.0747148675878803
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16742,96,1.24 [0.71-2.19],0.4510940571792651
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17517,871,0.84 [0.69-1.02],0.0705799366672543
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestine,16962,316,1.28 [0.93-1.75],0.1241357996560884
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23523,42,0.46 [0.20-1.06],0.0673899437969228
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of liver,23077,142,1.45 [0.92-2.29],0.1099506751777813
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of liver,23016,81,1.87 [1.03-3.39],0.0406060468499783
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22751,371,1.00 [0.75-1.33],0.9881526140512128
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholelithiasis,22649,269,0.78 [0.56-1.10],0.1580995221104012
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholecystitis,22446,66,1.64 [0.84-3.19],0.1464613671734363
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22413,33,1.73 [0.68-4.43],0.2515149768927158
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis,22455,75,1.35 [0.72-2.53],0.3550330553087831
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23726,75,1.33 [0.71-2.49],0.3708255861625283
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22528,322,0.96 [0.71-1.30],0.779979863446992
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22244,38,0.66 [0.27-1.61],0.3651456384304365
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Coeliac disease,22234,28,0.50 [0.18-1.40],0.1858479291572485
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22265,59,0.81 [0.40-1.65],0.5586056636872865
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22437,231,1.03 [0.72-1.47],0.8709254478786268
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,GI-bleeding,22433,227,1.02 [0.71-1.46],0.915245871787992
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20747,1491,1.08 [0.93-1.26],0.2859586360825357
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23472,93,0.83 [0.47-1.46],0.5155870867765725
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23538,452,1.12 [0.87-1.45],0.3833614722323314
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22299,459,1.41 [1.09-1.82],0.0087969476999818
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22906,467,0.79 [0.61-1.02],0.0701813484628655
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22545,106,0.96 [0.56-1.63],0.8726486301270717
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22740,301,0.95 [0.69-1.31],0.7614334003055618
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23649,94,1.05 [0.60-1.83],0.8620986931986497
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23634,79,0.96 [0.52-1.76],0.8879560636890924
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23614,59,0.84 [0.42-1.69],0.6228694789549893
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23593,58,nan [nan-nan],
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23591,56,nan [nan-nan],
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23141,55,0.66 [0.31-1.38],0.2672863518853093
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23455,369,1.25 [0.94-1.66],0.1325021306966916
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21922,82,1.01 [0.55-1.86],0.9732258378765568
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21885,45,3.12 [1.41-6.92],0.0049899186488087
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21880,40,2.32 [0.99-5.43],0.0525293956367495
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22023,183,1.08 [0.72-1.62],0.7140471244934383
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22002,162,1.08 [0.70-1.67],0.7211999474586799
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17673,3593,0.99 [0.90-1.11],0.922235089464486
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,19150,2113,1.01 [0.89-1.15],0.842136597147789
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21666,1088,0.97 [0.82-1.15],0.7148461955849426
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17127,90,1.25 [0.70-2.22],0.4502394992563391
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17452,415,1.02 [0.78-1.34],0.8914465632346374
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23658,87,1.26 [0.71-2.25],0.4267503919750318
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23663,77,1.29 [0.70-2.39],0.4132443644294528
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18110,1073,0.90 [0.75-1.07],0.2356503490810466
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",20556,1073,0.90 [0.75-1.07],0.2211125154915514
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17167,130,0.78 [0.48-1.27],0.324105560133015
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22961,126,0.78 [0.48-1.28],0.3319768770280696
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17205,168,0.89 [0.58-1.35],0.583012541372979
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17093,56,0.71 [0.34-1.48],0.3559879105416949
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17291,254,0.80 [0.56-1.13],0.2009302959161489
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23796,122,1.04 [0.64-1.69],0.88663993399405
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17616,579,1.01 [0.80-1.28],0.9304294597607284
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17344,307,0.79 [0.57-1.08],0.13897848776465
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18209,1172,1.02 [0.86-1.20],0.8511168512207052
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),17061,24,0.47 [0.15-1.47],0.1932831229949048
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),17085,48,1.22 [0.55-2.70],0.6189933334934388
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,17067,30,1.89 [0.71-5.03],0.1996034076622292
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),17052,15,0.55 [0.13-2.36],0.4219499681592636
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17641,604,1.15 [0.91-1.44],0.2491236078698078
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17564,527,1.17 [0.91-1.50],0.2150862542499949
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19309,261,0.97 [0.69-1.37],0.8618860314028296
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23629,36,3.53 [1.47-8.50],0.0048584355502732
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23611,18,0.78 [0.21-2.82],0.7012132978570355
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20913,45,1.89 [0.85-4.20],0.1209993423024301
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21157,289,0.89 [0.65-1.23],0.4883520123561454
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21703,835,0.90 [0.74-1.09],0.2754980951281589
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21032,164,0.78 [0.51-1.19],0.253757763262194
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20963,95,1.08 [0.62-1.89],0.7745205617772333
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21516,648,0.92 [0.74-1.15],0.4620731450386792
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20918,50,0.70 [0.32-1.52],0.3682924720351168
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21097,229,0.91 [0.63-1.31],0.6164576570070912
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20969,101,0.94 [0.54-1.63],0.8243037938209256
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20935,67,1.56 [0.80-3.03],0.1886571447005071
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20988,120,0.97 [0.59-1.60],0.9044889084594292
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20919,51,0.69 [0.32-1.48],0.339491395554043
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21129,261,0.98 [0.70-1.38],0.907160416621323
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20817,239,1.49 [1.05-2.13],0.0271123964483253
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20642,64,nan [nan-nan],
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20641,63,2.29 [1.17-4.49],0.0159976177273822
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20639,61,1.72 [0.85-3.49],0.1297742750118974
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20639,61,0.63 [0.31-1.29],0.207427423953359
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20753,175,0.57 [0.37-0.87],0.0086942900458574
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20742,164,0.57 [0.37-0.87],0.0100504525597453
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20831,253,0.87 [0.62-1.23],0.4332800977358756
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20630,52,1.12 [0.52-2.41],0.7648871367042966
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20665,87,0.75 [0.42-1.35],0.3370758066570436
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20692,114,0.58 [0.34-0.97],0.0375224420468597
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20619,41,2.05 [0.88-4.77],0.0958775234576993
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20929,351,1.00 [0.75-1.35],0.9843032957992576
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20722,144,1.09 [0.69-1.73],0.6968951068025824
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20767,189,1.15 [0.77-1.72],0.4823974565501814
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22887,106,0.89 [0.52-1.50],0.6549385161559983
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23077,296,1.00 [0.72-1.37],0.979466851612775
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22839,58,0.73 [0.36-1.51],0.3986589660190458
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22832,51,0.80 [0.37-1.73],0.5678500937787588
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22870,89,1.19 [0.66-2.12],0.5631882905497305
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18325,2378,1.49 [1.32-1.68],2.852081455498018e-10
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20606,1288,1.14 [0.97-1.33],0.1073271622714588
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,21098,307,9.08 [6.67-12.38],2.0323180561448258e-44
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20883,92,2.21 [1.24-3.96],0.0075043936329355
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21129,74,9.40 [5.03-17.60],2.3827416211585738e-12
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21148,93,,
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21148,93,,
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23416,358,1.09 [0.81-1.45],0.5701830683351083
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23382,76,4.17 [2.27-7.64],4.004685176010848e-06
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23311,253,1.18 [0.84-1.67],0.3329058475247483
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23191,133,0.93 [0.58-1.49],0.7632949623656622
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21685,844,1.15 [0.95-1.39],0.1608205026942671
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cystitis,20901,60,1.16 [0.57-2.36],0.675979733796141
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20915,74,0.69 [0.36-1.31],0.2538823896537805
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21229,388,1.25 [0.94-1.65],0.1244318277694147
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20981,140,1.25 [0.79-1.99],0.335957076718661
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21215,374,1.08 [0.81-1.43],0.6155096288999095
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19889,571,1.06 [0.84-1.35],0.6022263162426766
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19425,107,1.46 [0.86-2.47],0.1585430647462394
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hydrocele,19420,102,1.29 [0.75-2.21],0.3577446214163652
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19482,164,1.18 [0.77-1.81],0.4476320808678733
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19477,159,1.01 [0.65-1.56],0.9742620079712788
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19536,218,1.23 [0.85-1.79],0.2698207947390497
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23407,78,0.73 [0.39-1.35],0.3178079119721101
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21730,554,0.63 [0.50-0.80],0.0001561387974997
